CVA Family Office’s Mesoblast MESO Stock Holding History

CVA Family Office’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2K	Buy	+130	New	+$2.17K	﹤0.01%	1529

Other funds holding MESO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

CVA Family Office's MESO Position: Q1 2026 in Review

CVA Family Office opened a new position in Mesoblast (MESO) in Q1 2026: 130 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1529 among its holdings.

69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

CVA Family Office held 130 shares of Mesoblast worth $2K as of Q1 2026.
Mesoblast was a new CVA Family Office position in Q1 2026.
Mesoblast made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1529 holding.
69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.